
Welbusol Inhalation 1.25mg Solution
Marketer
Leeford Healthcare Ltd
Salt Composition
Levosalbutamol (1.25mg)
Uses of Welbusol Inhalation 1.25mg Solution
Persistent airflow limitation in the lungs
Major Benefits of Welbusol Inhalation 1.25mg Solution:
Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for usage guidelines.
Common Side effects of Welbusol Inhalation 1.25mg Solution:
- Bronchitis (inflammation of the airways)
- Dizziness
- Vomiting
- Inflammation of the nose
- Pain
- Asthma
- Pharyngitis
How to use Welbusol Inhalation 1.25mg Solution:
Follow your doctor's instructions precisely regarding dosage and treatment length. Always refer to the product label for usage guidelines.
How Welbusol Inhalation 1.25mg Solution works:
Airway relaxation is achieved with Welbusol Inhalation Solution 1.25mg, a bronchodilator that eases breathing by expanding the bronchial passages.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Welbusol Inhalation 1.25mg Solution during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Using Welbusol Inhalation Solution 1.25mg while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no identified risk to the infant.
DrivingNone
No known drug interactions.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Welbusol Inhalation 1.25mg Solution :
Omit any missed Welbusol Inhalation 1.25mg Solution dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Welbusol Inhalation 1.25mg Solution
| Label | Value |
|---|---|
| Chemical Type | Benzyl Alcohol Derivatives |
| Developing Habits | No. |
| Type of Therapy | Breathing |
| Actions | Short-acting beta-2 agonists |
